Your browser doesn't support javascript.
loading
A pilot study towards the immunological effects of omalizumab treatment used to facilitate oral immunotherapy in peanut-allergic adolescents.
van der Heiden, Marieke; Nopp, Anna; Brandström, Josef; Carvalho-Queiroz, Claudia; Nilsson, Caroline; Sverremark-Ekström, Eva.
Afiliação
  • van der Heiden M; Department of Molecular Biosciences, The Wenner-Gren Institute, Stockholm University, Stockholm, Sweden.
  • Nopp A; Sachs' Children and Youth Hospital, Södersjukhuset, Karolinska Institute, Stockholm, Sweden.
  • Brandström J; Department of Clinical Science and Education, Södersjukhuset, Karolinska Institute, Stockholm, Sweden.
  • Carvalho-Queiroz C; Sachs' Children and Youth Hospital, Södersjukhuset, Karolinska Institute, Stockholm, Sweden.
  • Nilsson C; Clinical Epidemiology Division, Department of Medicine, Karolinska Institute, Stockholm, Sweden.
  • Sverremark-Ekström E; Department of Neonatology, Karolinska University Hospital, Stockholm, Sweden.
Scand J Immunol ; 93(4): e13005, 2021 Apr.
Article em En | MEDLINE | ID: mdl-33244763

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Arachis / Alérgenos / Hipersensibilidade a Amendoim / Omalizumab Tipo de estudo: Guideline / Observational_studies / Risk_factors_studies Limite: Adolescent / Female / Humans / Male Idioma: En Ano de publicação: 2021 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Arachis / Alérgenos / Hipersensibilidade a Amendoim / Omalizumab Tipo de estudo: Guideline / Observational_studies / Risk_factors_studies Limite: Adolescent / Female / Humans / Male Idioma: En Ano de publicação: 2021 Tipo de documento: Article